Extracellular Vesicles for the Treatment of Syringomyelia
NCT07295067
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Syringomyelia
Interventions
DRUG:
Exosomes group
Sponsor
Xuanwu Hospital, Beijing
Collaborators
[object Object]